121 related articles for article (PubMed ID: 9395801)
1. Detection of low numbers of neuroblastoma cells in vitro.
Lai PS; Chee S; Chiu LL; Sano K
Ann Acad Med Singap; 1997 Jul; 26(4):415-20. PubMed ID: 9395801
[TBL] [Abstract][Full Text] [Related]
2. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction.
Mattano LA; Moss TJ; Emerson SG
Cancer Res; 1992 Sep; 52(17):4701-5. PubMed ID: 1380888
[TBL] [Abstract][Full Text] [Related]
3. Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction.
Kuroda T; Saeki M; Nakano M; Mizutani S
J Pediatr Surg; 1997 Jan; 32(1):69-72. PubMed ID: 9021573
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow.
Hoon DS; Kuo CT; Wen S; Wang H; Metelitsa L; Reynolds CP; Seeger RC
Am J Pathol; 2001 Aug; 159(2):493-500. PubMed ID: 11485908
[TBL] [Abstract][Full Text] [Related]
5. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.
Miyajima Y; Kato K; Numata S; Kudo K; Horibe K
Cancer; 1995 Jun; 75(11):2757-61. PubMed ID: 7743482
[TBL] [Abstract][Full Text] [Related]
6. Detection procedures for neuroblastoma cells metastatic to blood and bone marrow: blinded comparison of chromogranin A heminested reverse transcription polymerase chain reaction to tyrosine hydroxylase nested reverse transcription polymerase chain reaction and to anti-GD2 immunocytology.
Pagani A; Macri L; Faulkner LB; Tintori V; Paoli A; Garaventa A; Bussolati G
Diagn Mol Pathol; 2002 Jun; 11(2):98-106. PubMed ID: 12045713
[TBL] [Abstract][Full Text] [Related]
7. Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells.
Swerts K; De Moerloose B; Dhooge C; Vandesompele J; Hoyoux C; Beiske K; Benoit Y; Laureys G; Philippé J
Clin Chem; 2006 Mar; 52(3):438-45. PubMed ID: 16384890
[TBL] [Abstract][Full Text] [Related]
8. Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA.
Burchill SA; Bradbury FM; Selby P; Lewis IJ
Eur J Cancer; 1995; 31A(4):553-6. PubMed ID: 7576966
[TBL] [Abstract][Full Text] [Related]
9. Detection of neuroblastoma cells in blood by reverse transcriptase-polymerase chain reaction.
Gao Y; Li G; Zhang X; Xu Q; Zheng B
Chin Med J (Engl); 1997 May; 110(5):341-5. PubMed ID: 9594298
[TBL] [Abstract][Full Text] [Related]
10. Detection of the PGP9.5 and tyrosine hydroxylase mRNAs for minimal residual neuroblastoma cells in bone marrow and peripheral blood.
Yanagisawa TY; Sasahara Y; Fujie H; Ohashi Y; Minegishi M; Itano M; Morita S; Tsuchiya S; Hayashi Y; Ohi R; Konno T
Tohoku J Exp Med; 1998 Mar; 184(3):229-40. PubMed ID: 9591338
[TBL] [Abstract][Full Text] [Related]
11. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
Datta YH; Adams PT; Drobyski WR; Ethier SP; Terry VH; Roth MS
J Clin Oncol; 1994 Mar; 12(3):475-82. PubMed ID: 7509852
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fluorescent in situ hybridization (FISH) and the polymerase chain reaction (PCR) for detection of residual neuroblastoma cells.
Eckschlager T; McClain K
Neoplasma; 1996; 43(5):301-3. PubMed ID: 8996548
[TBL] [Abstract][Full Text] [Related]
13. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction.
Smith B; Selby P; Southgate J; Pittman K; Bradley C; Blair GE
Lancet; 1991 Nov; 338(8777):1227-9. PubMed ID: 1719320
[TBL] [Abstract][Full Text] [Related]
14. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.
Burchill SA; Bradbury MF; Pittman K; Southgate J; Smith B; Selby P
Br J Cancer; 1995 Feb; 71(2):278-81. PubMed ID: 7530983
[TBL] [Abstract][Full Text] [Related]
15. Real-time analysis of tyrosine hydroxylase gene expression: a sensitive and semiquantitative marker for minimal residual disease detection of neuroblastoma.
Lambooy LH; Gidding CE; van den Heuvel LP; Hulsbergen-van de Kaa CA; Ligtenberg M; Bökkerink JP; De Abreu RA
Clin Cancer Res; 2003 Feb; 9(2):812-9. PubMed ID: 12576454
[TBL] [Abstract][Full Text] [Related]
16. Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells.
Burchill SA; Lewis IJ; Selby P
Br J Cancer; 1999 Feb; 79(5-6):971-7. PubMed ID: 10070899
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of tyrosine hydroxylase mRNA for diagnosis and detection of minimal residual disease in neuroblastoma.
Ito R; Asami S; Kagawa S; Motohashi S; Shichino H; Chin M; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
Biol Pharm Bull; 2004 Mar; 27(3):315-8. PubMed ID: 14993794
[TBL] [Abstract][Full Text] [Related]
18. Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood.
Pittman K; Burchill S; Smith B; Southgate J; Joffe J; Gore M; Selby P
Ann Oncol; 1996 Mar; 7(3):297-301. PubMed ID: 8740795
[TBL] [Abstract][Full Text] [Related]
19. Highly sensitive assessment of neuroblastoma minimal residual disease in ovarian tissue using RT-qPCR-A strategy for improving the safety of fertility restoration.
Grèze V; Brugnon F; Chambon F; Halle P; Canis M; Amiot C; Grémeau AS; Pereira B; Yáñez Peralta Y; Tchirkov A; Kanold J
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27734578
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA.
Burchill SA; Bradbury FM; Smith B; Lewis IJ; Selby P
Int J Cancer; 1994 Jun; 57(5):671-5. PubMed ID: 7910809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]